FindTrial
Sign In

Intranasal Oxytocin (IN-OXT)

DRUG5 trials

Sponsors

Montefiore Medical Center, Eric Hollander, Elizabeth Austen Lawson, University of Electronic Science and Technology of China, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Conditions

HealthyHyperphagiaPrader-Willi SyndromeSelf-compassion Training (SCT) Plus Intranasal OxytocinSelf-compassion Training (SCT) Plus Intranasal PlaceboVasopressin Deficiency

Phase 1

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
RecruitingNCT04789148
Elizabeth Austen LawsonVasopressin Deficiency
Start: 2025-09-10End: 2027-06-01Target: 40Updated: 2026-07-23

Phase 2

Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
CompletedNCT02629991
Montefiore Medical CenterHyperphagia, Prader-Willi Syndrome
Start: 2015-10-31End: 2018-05-31Updated: 2021-10-07
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
CompletedNCT03197662
Eric HollanderHyperphagia, Prader-Willi Syndrome
Start: 2018-04-11End: 2022-08-29Updated: 2025-02-07
Oxytocin Plus Self-compassion Training in Borderline Personality Disorder
RecruitingNCT07551882
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauSelf-compassion Training (SCT) Plus Intranasal Oxytocin, Self-compassion Training (SCT) Plus Intranasal Placebo
Start: 2024-01-10End: 2026-08-01Target: 80Updated: 2026-04-27

Unknown Phase

The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling
CompletedNCT06605300
University of Electronic Science and Technology of ChinaHealthy
Start: 2024-10-02End: 2025-08-12Updated: 2025-10-03